Product
Crenolanib
Aliases
CP-868,596-26, Crenolanib besylate
4 clinical trials
2 indications
Indication
Acute Myeloid LeukemiaClinical trial
A Phase II Study of Crenolanib Besylate Maintenance Following Allogeneic Stem Cell Transplantation in Patients With FLT3-positive Acute Myeloid LeukemiaStatus: Completed, Estimated PCD: 2022-05-01
Clinical trial
Pilot Study of Crenolanib Combined With Standard Salvage Chmetherapy in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaStatus: Completed, Estimated PCD: 2018-02-01
Clinical trial
Phase I-II Study of Crenolanib Combined With Standard Salvage Chemotherapy, and Crenolanib Combined With 5-Azacitidine in Acute Myeloid Leukemia Patients With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2020-07-15
Clinical trial
A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2019-04-01